Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112749315 | 11274931 | 5 | F | 20140716 | 20160926 | 20150716 | 20160929 | PER | PHHY2015US041048 | NOVARTIS | 53.45 | YR | F | Y | 0.00000 | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112749315 | 11274931 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK | 22527 | CAPSULE | |||||||||
| 112749315 | 11274931 | 2 | C | ESTRACE | ESTRADIOL | 1 | Unknown | 0.01 %, UNK | 0 | .01 | PCT | ||||||||
| 112749315 | 11274931 | 3 | C | ESTRACE | ESTRADIOL | 1 | Unknown | 0.01 %, UNK | 0 | .01 | PCT |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112749315 | 11274931 | 1 | Multiple sclerosis |
| 112749315 | 11274931 | 2 | Atrophic vulvovaginitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112749315 | 11274931 | Lymphocyte count decreased | |
| 112749315 | 11274931 | Papilloma viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112749315 | 11274931 | 2 | 20140918 | 20141016 | 0 | |
| 112749315 | 11274931 | 3 | 20150107 | 0 |